None of the authors declares any conflict of interest with respect to the treatments investigated by this study.
Can body mass index help predict outcome in patients with bipolar disorder?
Version of Record online: 10 AUG 2009
© 2009 The Authors. Journal compilation © 2009 John Wiley & Sons A/S
Volume 11, Issue 6, pages 650–656, September 2009
How to Cite
Calkin, C., Van De Velde, C., Růžičková, M., Slaney, C., Garnham, J., Hajek, T., O’Donovan, C. and Alda, M. (2009), Can body mass index help predict outcome in patients with bipolar disorder?. Bipolar Disorders, 11: 650–656. doi: 10.1111/j.1399-5618.2009.00730.x
Results of this study were presented at the annual conference of the American Psychiatric Association, May 3–8, 2008, Washington DC, USA.
- Issue online: 10 AUG 2009
- Version of Record online: 10 AUG 2009
- Received 15 December 2008, revised and accepted for publication 15 May 2009
- bipolar disorder;
- body mass index;
- clinical characteristics;
- clinical correlates;
- clinical course;
Objective: Several studies have reported higher prevalence of obesity in patients suffering from bipolar disorder (BD). To study the relation of elevated body mass index (BMI) in patients with BD more closely, we investigated differences in sociodemographic, clinical, and medical characteristics with respect to BMI, with the hypothesis that BMI is related to prognosis and outcome.
Methods: We measured the BMI of 276 subjects of a tertiary care sample from the Maritime Bipolar Registry. Subjects were 16 to 83 years old, with psychiatric diagnoses of bipolar I disorder (n = 186), bipolar II disorder (n = 85), and BD not otherwise specified (n = 5). The registry included basic demographic data and details of the clinical presentation. We first examined the variables showing a significant association with BMI; subsequently, we modeled the relationship between BMI and psychiatric outcome using structural equation analysis.
Results: The prevalence of obesity in our sample was 39.1%. We found higher BMI in subjects with a chronic course (p < 0.001) and longer duration of illness (p = 0.02), lower scores on the Global Assessment of Functioning Scale (p = 0.02), and on disability (p = 0.002). Overweight patients had more frequent comorbid subthreshold social (p = 0.02) and generalized anxiety disorders (p = 0.05), diabetes mellitus type II (p < 0.001), and hypertension (p = 0.001). Subjects who achieved complete remission of symptoms on lithium showed significantly lower BMI (p = 0.01).
Conclusions: Our findings suggest that BMI is associated with the prognosis and outcome of BD. Whether this association is causal remains to be determined.